DISH Network’s Bid for Attorney Fees Rejected: Implications for Patent Suits and Fee Shifting Norms

The U.S. Court of Appeals recently rebuffed the bid by DISH Network LLC to recoup attorney fees from a law firm that represented a company DISH termed as a “judgment-proof shell.” The entity in question had unsatisfactorily sued DISH on charges of patent infringements. Bloomberg Law provides a detailed account of the case. It’s important…

Read More

IP Litigator Grace Pan Joins Carlton Fields, Bolstering National Intellectual Property Division

Renowned intellectual property litigator, Grace Pan, is the latest addition to the impressive roster of Carlton Fields. She has joined as a shareholder in the national intellectual property division based out of New York, as announced by the firm earlier this week. Pan’s practice centers around IP litigation, patent law, trade dress, and trade secrets….

Read More

FDA Accelerates Approval for Amgen’s Tarlatamab as Second-Line Treatment for Small Cell Lung Cancer

Small cell lung cancer often responds initially to chemotherapy, but relapses are common and secondary treatment options can offer limited benefits. This was taken into consideration in the recent FDA approval of a promising new drug from biopharma giant Amgen, providing these complex patients with one more potential treatment option. The drug, known as tarlatamab,…

Read More

Hyatt’s 19-Year USPTO Battle Dismissed: The Consequences of Flooding Patent Applications

In a significant turn of recent events, Gilbert Hyatt’s 19-year-old legal fight against the US Patent and Trademark Office (USPTO) has been dismissed by a federal judge. The ruling was heavily influenced by a prior Federal Circuit ruling and Hyatt’s own failure in timely reviewing hundreds of his patent applications. The Nevada-base prolific inventor has…

Read More

Patent Examiner’s Dilemma: Ethical Implications Amid Israeli Defense Contractor Controversy

An anonymous post on Reddit has recently garnered significant attention from several high-ranking Republicans in Congress and the Director of the U.S. Patent and Trademark Office (USPTO). The post is allegedly authored by a patent examiner who expressed ambivalence over granting a patent to an Israeli defense contractor given the continued conflict in Gaza. Given…

Read More

Intellectual Property Veteran Chao “Wendy” Wang Joins Baker Botts as Partner

In a recent style=”color:#000;”>report, the legal firm Baker Botts announced the addition of Chao “Wendy” Wang to its team as a partner within the Intellectual Property (IP) department. Based in the firm’s Palo Alto, California office, Wang has already established her focus for her tenure with the company. Throughout her career, Wang has centered her…

Read More

Navigating Patent Enforcement on Amazon: How Recent Ruling Impacts Declaratory Judgment Jurisdiction

In the constantly evolving landscape of global commerce, one of the biggest players that have fundamentally changed the way we live is Amazon. Routinely delivering a variety of products to our doorsteps, potentially saving hours of shopping elsewhere, Amazon stands as a testament to how intricately human and technological elements can interact to profoundly simplify…

Read More

Norton Rose Fulbright Boosts Intellectual Property Practice with Trio from Polsinelli

In a recent move aimed at strengthening their intellectual property practice, Norton Rose Fulbright has welcomed Adam Rehm and Rhiannon D’Agostin as partners. Also adding to their team is Zack Cleary, who joins in the capacity of counsel. All three members were previously associated with Polsinelli. Adam Rehm, based in Dallas, is a seasoned professional…

Read More

Fox Rothschild Bolsters Seattle IP Practice with Addition of Three Prominent Partners

The multinational law firm Fox Rothschild welcomed Samuel E. Webb, Brooke L. Sargeant, and Eileen S. Sun as partners to their intellectual property (IP) practice group in Seattle on Friday, as reported by Bloomberg Law Automation. Webb has a strong resume guiding clients through intellectual property aspects associated with funding events, acquisitions, licensing transactions, and…

Read More

AI-Driven Drug Discovery’s Legal Complexities: Intellectual Property Rights and Patent Exclusivity Under Scrutiny

Emerging technologies such as Artificial Intelligence (AI) are increasingly playing a significant role in multiple sectors, one of which is drug discovery in the pharmaceutical industry. The number of startup drug candidate pipelines utilizing AI tools is said to now tally to an approximate 50% of the preclinical programs of large pharmaceutical firms (Jayatunga et…

Read More

Shifting Dynamics in IP Litigation: Serving Chinese Defendants with Alternative Methods

In one of the more recent instances that sparked my memory, I thought back to a decision made in the Western District of Texas. This decision involved three topics I find especially interesting: China, Amazon, and the challenges involved with serving foreign defendants. This particular case concerned Intellectual Property (IP) rights and brought me back…

Read More

FTC Noncompete Ban: Unintended Consequences in Patent Filings and Trade Secrets Battle

The US Federal Trade Commission’s (FTC) recent enactment against employer noncompete agreements may result in an increase in patent filings and trade secrets litigation. Evidently, this move is a consequence of companies’ strategies to fortify their intellectual property rights, particularly against employees who depart their workforces. As announced on April 23rd, the FTC’s final rule…

Read More

Prominent Attorney Michael Siekman Joins Goodwin’s Life Sciences Practice

Goodwin, a prominent player in the field of legal practice, welcomes renowned legal practitioner Michael Siekman to their ever-expanding life sciences department. Based out of the Boston office, Siekman was officially announced as a partner on Monday. Siekman brings a wealth of legal expertise to the table, particularly within biotechnology, biosimilars, and pharmaceutical sectors. His…

Read More

Building a Strong Legal Team: Essential Strategy for Pharma and Medical Device Startups

Pharmaceutical and medical device startups face a unique set of challenges, including but not limited to, hiring, conducting clinical trials and finding investors. These stumbling blocks necessitate the assembly of a strong legal team early in the process, to better mitigate risks and establish a robust company foundation, as observed by Tucker Ellis attorneys Mollie…

Read More

NetScout Systems Victorious as Federal Circuit Nullifies $3.35 Million Infringement Award

In an impactful decision, the Federal Circuit invalidated patents owned by Packet Intelligence LLC, consequently nullifying a $3.35 million infringement award previously handed to network security company, NetScout Systems Inc. This ruling signifies a considerable victory for NetScout Systems, which has been contesting Packet Intelligence’s lawsuit since 2016 in the US District Court for the…

Read More